Amneal Pharmaceuticals, Inc. (AMRX) Deferred Tax Assets, Valuation Allowance USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Amneal Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2015 to 2024.
  • Amneal Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending March 31, 2024 was $566 M, a 30% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $566 M +$131 M +30% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $567 M +$132 M +30.3% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $435 M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $435 M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $435 M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $435 M +$18.3 M +4.4% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $417 M -$6.22 M -1.47% Dec 31, 2021 10-K 2024-03-14
Q4 2020 $423 M -$47.4 M -10.1% Dec 31, 2020 10-K 2024-03-14
Q4 2019 $470 M +$429 M +1040% Dec 31, 2019 10-K 2023-03-03
Q3 2019 $372 M Sep 30, 2019 10-Q 2019-11-07
Q4 2018 $41.2 M -$382 K -0.92% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $41.6 M -$614 K -1.45% Dec 31, 2017 10-K 2021-03-01
Q4 2016 $42.2 M +$19.7 M +87.1% Dec 31, 2016 10-K 2020-03-02
Q4 2015 $22.6 M Dec 31, 2015 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.